Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
194.13
-1.49 (-0.76%)
At close: Feb 18, 2026, 4:00 PM EST
193.50
-0.63 (-0.32%)
After-hours: Feb 18, 2026, 7:46 PM EST

Biogen Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
28,49025,81822,28337,49539,87735,242
Market Cap Growth
35.84%15.86%-40.57%-5.97%13.15%-6.47%
Enterprise Value
30,89028,44827,23542,91840,73139,390
Last Close Price
195.62175.99152.92258.77276.92239.92
PE Ratio
22.0919.9713.6532.2913.0922.65
Forward PE
12.3913.669.7117.5417.7013.94
PS Ratio
2.882.612.303.813.923.21
PB Ratio
1.571.411.332.532.983.22
P/TBV Ratio
11.019.9840.82172.636.8812.10
P/FCF Ratio
13.8912.598.1929.5234.8610.42
P/OCF Ratio
12.9211.717.7524.2328.819.68
PEG Ratio
4.054.751.904.3817.6839.30
EV/Sales Ratio
3.122.882.824.364.003.59
EV/EBITDA Ratio
8.577.898.4117.9311.5210.04
EV/EBIT Ratio
10.9410.0710.6222.6013.4911.47
EV/FCF Ratio
15.0613.8710.0133.7935.6011.65
Debt / Equity Ratio
0.370.370.400.500.500.70
Debt / EBITDA Ratio
1.791.792.002.931.851.91
Debt / FCF Ratio
3.253.252.475.855.872.28
Net Debt / Equity Ratio
0.130.130.260.430.080.27
Net Debt / EBITDA Ratio
0.670.671.342.670.320.76
Net Debt / FCF Ratio
1.181.181.605.020.970.89
Asset Turnover
0.340.340.350.380.420.45
Inventory Turnover
0.900.900.851.311.691.74
Quick Ratio
1.701.700.771.042.391.34
Current Ratio
2.682.681.352.002.991.83
Return on Equity (ROE)
7.39%7.39%10.36%8.24%24.33%15.96%
Return on Assets (ROA)
6.14%6.14%5.84%4.62%7.79%8.86%
Return on Invested Capital (ROIC)
11.19%11.13%10.40%9.35%16.55%21.63%
Return on Capital Employed (ROCE)
10.80%10.80%11.40%8.10%14.20%17.50%
Earnings Yield
4.54%5.01%7.32%3.10%7.64%4.42%
FCF Yield
7.20%7.94%12.21%3.39%2.87%9.60%
Buyback Yield / Dilution
-0.82%-0.82%-0.21%0.27%2.41%7.25%
Updated Feb 6, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q